News & Analysis on Clinical Trial Services & Contract Research And Development
Concerns recently introduced import laws would cause EU-wide API shortages now appear unfounded, but European industry groups say the buffering effects of stockpiling mean it is still too early to be sure supplies will not be affected.
Dispatches from AAPS
There are multiple ways to make amorphous dispersions in order to enhance bioavailability but spray dry dispersion (SDD) is often the most applicable, Bend Research says.
Dispatches from AAPS
Understanding how a drug will interact with food is vital even if predicting it accurately during development can be a challenge according to speakers at AAPS yesterday.
Hospira has received a Form 483 from the US Food and Drug Administration (FDA) noting three observations at its Kansas manufacturing facility.
India’s CDSCO has unveiled a list of clinical trial regulations that does little to explain how they will fix a system that has seen an increasing number of companies pulling their operations from the country.